Insider Transactions in Q1 2024 at Pacira Bio Sciences, Inc. (PCRX)
Insider Transaction List (Q1 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 08
2024
|
Gary W Pace Director |
SELL
Open market or private sale
|
Direct |
90,000
-80.27%
|
$2,700,000
$30.6 P/Share
|
|
Mar 07
2024
|
Gary W Pace Director |
SELL
Open market or private sale
|
Direct |
28,257
-20.13%
|
$847,710
$30.81 P/Share
|
|
Mar 06
2024
|
Gary W Pace Director |
SELL
Open market or private sale
|
Direct |
1,066
-0.75%
|
$30,914
$29.67 P/Share
|
|
Feb 05
2024
|
Kristen Marie Williams Chief Administrative Officer |
BUY
Grant, award, or other acquisition
|
Direct |
33,700
+36.32%
|
-
|
|
Feb 05
2024
|
Daryl Gaugler Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
33,700
+33.97%
|
-
|
|
Jan 02
2024
|
Lauren Bullaro Riker Senior Vice President, Finance |
SELL
Payment of exercise price or tax liability
|
Direct |
159
-0.7%
|
$5,088
$32.0 P/Share
|
|
Jan 02
2024
|
Frank D. Lee Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
99,520
+50.0%
|
-
|
|
Jan 02
2024
|
Jonathan Slonin Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,000
+8.9%
|
-
|